CD274 and cancer: Based on reports demonstrating that soluble PD-1 is connected to an advanced disease state in different malignancies and is functional in activating PD-L1 (as indicated for example by regulation of immune activities) [35,36,37,38,39], the effects of PD-1 in both systems were determined by exposing the cancer cells to a soluble PD-1 protein.